COVID-19
In close collaboration with the European Commission, the European Medicines Agency and other European and national competent authorities, AESGP is coordinating efforts to inform, predict and resolve problems to ensure an uninterrupted supply of self-care products.
AESGP's response to COVID-19
COVID-19
Evidence Summary
Self-care
AESGP releases new Evidence Summary on the importance of self-care during the COVID-19 pandemic
COVID-19
Self-care
Shortages
Statement
Remarks on EU4Health Programme
COVID-19
Response to EPF's Open Memo to the Health Industry
COVID-19
European Industry trade and supply chain needs to respond to Covid-19
COVID-19
Statement
EU Health Coalition calls for more solidarity and coordinated EU action to tackle COVID-19
COVID-19
Medical Devices
OTC
Self-care
AESGP and the COVID-19 pandemic
COVID-19
Covid-19: AESGP continuity planning
COVID-19
OTC
Press release
Self-care
WHO confirms no scientific evidence linking ibuprofen and the worsening of COVID-19
COVID-19
EMA
OTC
Press release
Self-care
No link between the use of ibuprofen and worsening of COVID-19
COVID-19
Self-care